Cargando…
Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway
BACKGROUND: Heterologous expression systems based on promoters inducible with isopropyl-β-D-1-thiogalactopyranoside (IPTG), e.g., Escherichia coli BL21(DE3) and cognate LacI(Q)/P(lacUV5)-T7 vectors, are commonly used for production of recombinant proteins and metabolic pathways. The applicability of...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687329/ https://www.ncbi.nlm.nih.gov/pubmed/26691337 http://dx.doi.org/10.1186/s12934-015-0393-3 |
_version_ | 1782406613815001088 |
---|---|
author | Dvorak, Pavel Chrast, Lukas Nikel, Pablo I. Fedr, Radek Soucek, Karel Sedlackova, Miroslava Chaloupkova, Radka de Lorenzo, Víctor Prokop, Zbynek Damborsky, Jiri |
author_facet | Dvorak, Pavel Chrast, Lukas Nikel, Pablo I. Fedr, Radek Soucek, Karel Sedlackova, Miroslava Chaloupkova, Radka de Lorenzo, Víctor Prokop, Zbynek Damborsky, Jiri |
author_sort | Dvorak, Pavel |
collection | PubMed |
description | BACKGROUND: Heterologous expression systems based on promoters inducible with isopropyl-β-D-1-thiogalactopyranoside (IPTG), e.g., Escherichia coli BL21(DE3) and cognate LacI(Q)/P(lacUV5)-T7 vectors, are commonly used for production of recombinant proteins and metabolic pathways. The applicability of such cell factories is limited by the complex physiological burden imposed by overexpression of the exogenous genes during a bioprocess. This burden originates from a combination of stresses that may include competition for the expression machinery, side-reactions due to the activity of the recombinant proteins, or the toxicity of their substrates, products and intermediates. However, the physiological impact of IPTG-induced conditional expression on the recombinant host under such harsh conditions is often overlooked. RESULTS: The physiological responses to IPTG of the E. coli BL21(DE3) strain and three different recombinants carrying a synthetic metabolic pathway for biodegradation of the toxic anthropogenic pollutant 1,2,3-trichloropropane (TCP) were investigated using plating, flow cytometry, and electron microscopy. Collected data revealed unexpected negative synergistic effect of inducer of the expression system and toxic substrate resulting in pronounced physiological stress. Replacing IPTG with the natural sugar effector lactose greatly reduced such stress, demonstrating that the effect was due to the original inducer’s chemical properties. CONCLUSIONS: IPTG is not an innocuous inducer; instead, it exacerbates the toxicity of haloalkane substrate and causes appreciable damage to the E. coli BL21(DE3) host, which is already bearing a metabolic burden due to its content of plasmids carrying the genes of the synthetic metabolic pathway. The concentration of IPTG can be effectively tuned to mitigate this negative effect. Importantly, we show that induction with lactose, the natural inducer of P(lac), dramatically lightens the burden without reducing the efficiency of the synthetic TCP degradation pathway. This suggests that lactose may be a better inducer than IPTG for the expression of heterologous pathways in E. coli BL21(DE3). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-015-0393-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4687329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46873292015-12-23 Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway Dvorak, Pavel Chrast, Lukas Nikel, Pablo I. Fedr, Radek Soucek, Karel Sedlackova, Miroslava Chaloupkova, Radka de Lorenzo, Víctor Prokop, Zbynek Damborsky, Jiri Microb Cell Fact Research BACKGROUND: Heterologous expression systems based on promoters inducible with isopropyl-β-D-1-thiogalactopyranoside (IPTG), e.g., Escherichia coli BL21(DE3) and cognate LacI(Q)/P(lacUV5)-T7 vectors, are commonly used for production of recombinant proteins and metabolic pathways. The applicability of such cell factories is limited by the complex physiological burden imposed by overexpression of the exogenous genes during a bioprocess. This burden originates from a combination of stresses that may include competition for the expression machinery, side-reactions due to the activity of the recombinant proteins, or the toxicity of their substrates, products and intermediates. However, the physiological impact of IPTG-induced conditional expression on the recombinant host under such harsh conditions is often overlooked. RESULTS: The physiological responses to IPTG of the E. coli BL21(DE3) strain and three different recombinants carrying a synthetic metabolic pathway for biodegradation of the toxic anthropogenic pollutant 1,2,3-trichloropropane (TCP) were investigated using plating, flow cytometry, and electron microscopy. Collected data revealed unexpected negative synergistic effect of inducer of the expression system and toxic substrate resulting in pronounced physiological stress. Replacing IPTG with the natural sugar effector lactose greatly reduced such stress, demonstrating that the effect was due to the original inducer’s chemical properties. CONCLUSIONS: IPTG is not an innocuous inducer; instead, it exacerbates the toxicity of haloalkane substrate and causes appreciable damage to the E. coli BL21(DE3) host, which is already bearing a metabolic burden due to its content of plasmids carrying the genes of the synthetic metabolic pathway. The concentration of IPTG can be effectively tuned to mitigate this negative effect. Importantly, we show that induction with lactose, the natural inducer of P(lac), dramatically lightens the burden without reducing the efficiency of the synthetic TCP degradation pathway. This suggests that lactose may be a better inducer than IPTG for the expression of heterologous pathways in E. coli BL21(DE3). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-015-0393-3) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-21 /pmc/articles/PMC4687329/ /pubmed/26691337 http://dx.doi.org/10.1186/s12934-015-0393-3 Text en © Dvorak et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Dvorak, Pavel Chrast, Lukas Nikel, Pablo I. Fedr, Radek Soucek, Karel Sedlackova, Miroslava Chaloupkova, Radka de Lorenzo, Víctor Prokop, Zbynek Damborsky, Jiri Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway |
title | Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway |
title_full | Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway |
title_fullStr | Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway |
title_full_unstemmed | Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway |
title_short | Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway |
title_sort | exacerbation of substrate toxicity by iptg in escherichia coli bl21(de3) carrying a synthetic metabolic pathway |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687329/ https://www.ncbi.nlm.nih.gov/pubmed/26691337 http://dx.doi.org/10.1186/s12934-015-0393-3 |
work_keys_str_mv | AT dvorakpavel exacerbationofsubstratetoxicitybyiptginescherichiacolibl21de3carryingasyntheticmetabolicpathway AT chrastlukas exacerbationofsubstratetoxicitybyiptginescherichiacolibl21de3carryingasyntheticmetabolicpathway AT nikelpabloi exacerbationofsubstratetoxicitybyiptginescherichiacolibl21de3carryingasyntheticmetabolicpathway AT fedrradek exacerbationofsubstratetoxicitybyiptginescherichiacolibl21de3carryingasyntheticmetabolicpathway AT soucekkarel exacerbationofsubstratetoxicitybyiptginescherichiacolibl21de3carryingasyntheticmetabolicpathway AT sedlackovamiroslava exacerbationofsubstratetoxicitybyiptginescherichiacolibl21de3carryingasyntheticmetabolicpathway AT chaloupkovaradka exacerbationofsubstratetoxicitybyiptginescherichiacolibl21de3carryingasyntheticmetabolicpathway AT delorenzovictor exacerbationofsubstratetoxicitybyiptginescherichiacolibl21de3carryingasyntheticmetabolicpathway AT prokopzbynek exacerbationofsubstratetoxicitybyiptginescherichiacolibl21de3carryingasyntheticmetabolicpathway AT damborskyjiri exacerbationofsubstratetoxicitybyiptginescherichiacolibl21de3carryingasyntheticmetabolicpathway |